ArticleFrontiers in oncology2026

Exceptional 106-month survival in multiply relapsed small cell lung cancer after sequential anlotinib and short-course sintilimab: a case report.

Ruzhu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.